{
"NDC": {
"NDCCode": "31722-691-47",
"PackageDescription": "473 mL in 1 BOTTLE (31722-691-47) ",
"NDC11Code": "31722-0691-47",
"ProductNDC": "31722-691",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Spironolactone",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Spironolactone",
"DosageFormName": "SUSPENSION",
"RouteName": "ORAL",
"StartMarketingDate": "20250221",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA218085",
"LabelerName": "Camber Pharmaceuticals, Inc.",
"SubstanceName": "SPIRONOLACTONE",
"StrengthNumber": "25",
"StrengthUnit": "mg/5mL",
"Pharm_Classes": "Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-04-10",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20250221",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}